Upcoming Webinar
Instrumentl Fall Launch: Grant Work, Leveled Up.
Thu, Oct 29
or
Wed, Nov 4
@ 2PM ET
Why Instrumentl
Full Cycle Grant Platform
By Customer
Featured
$1.1m More Per Year
The Instrumentl Impact Report
Explore
Learn
Connect
Find the perfect Grants for Teachers Continuing Education in Puerto Rico on Instrumentl. 9,000+ Grants for Teachers Continuing Education in Puerto Rico in the United States.
9,000+
Available grants
$2.55B
Total funding
$5K
Median grant
Skip the search. Get matched with grants that fit your non-profit.
Smart recommendations based on your profile — in minutes.
OREF/Musculoskeletal Transplant Foundation Research Grant
Solicits investigator-initiated proposals focusing on research in the science of biologic – reconstruction, bone regeneration, transplantation - allografts, and including stem cells for graft transplantation.
Accelerating the Development of Combined CGM–Pump Devices
A combined continuous glucose monitor (CGM) and insulin pump device represents an innovative approach to simplifying diabetes management by integrating two essential technologies into a single device. This approach has the potential to improve quality of life for people with type 1 diabetes (T1D) by reducing the burden associated with wearing and managing multiple devices.
Despite this promise, the development of combined CGM–pump devices presents technical and commercialization challenges. These include the need for further advances in device compatibility and lifespan, system reliability, and scalable manufacturing, while maintaining affordability and broadaccessibility. In addition, a potential insulin dilution effect may require adjustment of the CGM algorithm.
Breakthrough T1D invites applications for research and development projects that address key technical, clinical, and translational challenges related to combined CGM–pump devices, with the goal of accelerating their development and improving outcomes for people living with T1D.
In response to this announcement, applications may request up to a total of $900,000 USD for up to three years.
Hemophilia Fellowship
This competitive grant program seeks to support an institution-based fellowship that emphasizes shared decision making (SDM), patient education, and multidisciplinary team-based care. The intent is to strengthen the hemophilia care through equitable education, and patient-centered shared decision making in a rapidly evolving treatment landscape.
Geographic Scope
Funding Range and Project Length
Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
Alopecia Areata (AA) is a chronic, immune-mediated condition causing nonscarring hair loss that affects about 2% of the global population and can lead to substantial psychosocial burden if disease is severe and untreated. The treatment landscape has recently evolved with the approval of ritlecitinib, a systemic therapy for severe AA in adults and adolescents aged 12 years and older, based on efficacy demonstrated in the ALLEGRO phase 2b/3 program.
Despite this advance, important questions remain regarding the optimal timing of therapy initiation. Emerging post-hoc analyses from the ALLEGRO program indicate that patients with shorter disease duration and lower baseline severity achieve higher response rates, suggesting that earlier intervention with ritlecitinib may lead to improved outcomes.
Geographic Scope
United States
Funding Range and Project Length
Individual projects requesting up to $100,000 USD will be considered.
Maximum project length is 24 months.
Patrick J. Kiley / Houston AGC Scholarship
Benefiting employees, dependents of employees, and/or interns of AGC Houston member firms OR students involved in AGC Student Chapters.
Award Amounts
Multiple awards are given each year. Scholarship award amounts will vary for each selected scholarship recipient.
Myasthenia Gravis Rare Disease Network (MGNet)
The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.
Diseases Studied
Myasthenia Gravis (MG) and its subtypes:
Goals, Mission, & Vision
The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:
Scholar Awards
Objectives
There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.
Award Description
The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.Myasthenia Gravis Rare Disease Network (MGNet)
The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.
Diseases Studied
Myasthenia Gravis (MG) and its subtypes:
Goals, Mission, & Vision
The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:
Pilot and Feasibility Grants
Objectives
MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.
The priorities of the Pilot Grant Program are:
Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.
Funding
The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.
Looking for grants for teachers continuing education in Puerto Rico?
Read more about each grant below or start your 14-day free trial to see all grants for teachers continuing education in Puerto Rico recommended for your specific programs.
How common are grants in this category?
Quite common — grants in this category are more prevalent than in others.
Over the past year, when are grant deadlines typically due for grants for Teachers Continuing Education in Puerto Rico?
Most grants are due in the first quarter.
What's the typical grant amount funded for Grants for Teachers Continuing Education in Puerto Rico?
Grants are most commonly $325,000.
What's the typical amount funded for Puerto Rico?
Grants are most commonly $104,638.
What's the total number of grants in Grants for Teachers Continuing Education in Puerto Rico year over year?
In 2024, funders in Puerto Rico awarded a total of 1,758 grants.
Among all the Grants for Teachers Continuing Education in Puerto Rico given out in Puerto Rico, the most popular focus areas that receive funding are Education, Human Services, and Human Service Organizations.
1. Education
2. Human Services
3. Human Service Organizations
How is funding for Grants for Teachers Continuing Education in Puerto Rico changing over time?
Funding has increased by 15.38%.
How does grant funding vary by county?
San Juan County, Dorado County, and Loiza County receive the most funding.
| County | Total Grant Funding in 2024 |
|---|---|
| San Juan County | $85,833,046 |
| Dorado County | $27,296,199 |
| Loiza County | $11,736,039 |
| Bayamon County | $11,338,985 |
| Vega Alta County | $9,404,211 |